Navigation Links
Teva Launches National Advocacy Campaign for Affordable Healthcare
Date:2/11/2009

WASHINGTON, Feb. 11 /PRNewswire-USNewswire/ -- Teva Pharmaceuticals USA, the leading generic pharmaceutical company, today announced that it was launching a nationwide campaign to push for more affordable healthcare. The program, called the "Year of Affordable Healthcare" commemorates the 25th anniversary of the landmark Waxman-Hatch Act which created the modern generic drugs industry and has resulted in billions of dollars of savings.

"With a new administration and Congress, and so many Americans concerned by the economy, this is the right time for federal action to increase access to healthcare through smart policy," said Bill Marth, President and CEO of Teva North America. "As a leader in the generics industry, Teva will highlight the fact that reducing the cost of healthcare does not mean reducing the quality of healthcare."

Currently, one out of every seven prescriptions in the United States is filled with a Teva product, and one out of every four generic prescriptions.

The Year of Affordable Healthcare campaign kicks off today with the release of a national poll that finds many Americans, due to the economic crisis, have skipped their doses of medication to save money. There is strong support among respondents for increasing the use of generic medicines as a way to reform the system and reduce costs.

Teva also released the first in a series of videos (available at www.yearofaffordablehealth.com/gallery) designed to illustrate the important savings generic drugs have produced for everyday Americans since Waxman-Hatch passed.

The "Year of Affordable Healthcare" campaign will also include:

  • Several regional forums to explore voter priorities for health care reform in 2009, which will be enshrined in a report to Congress later in the year;
  • Interactive, new media initiatives meant to engage Americans at the grassroots-level to support the priorities of Year of Affordable Healthcare;
  • Additional polls to track American sentiments on healthcare amid the economic crisis throughout the year;
  • Stakeholder outreach to local political and healthcare leaders in major cities to join the campaign.

About Teva

Teva USA is a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd., one of the largest generic pharmaceutical companies in the world and among the top 20 pharmaceutical companies.


'/>"/>
SOURCE Teva Pharmaceuticals USA
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. EngagementHealth(R) Launches Comprehensive Wellness Program with Hendrix College - 96 Percent of Hendrix Faculty and Staff Volunteer to Participate
2. C4CC Education Fund Launches Discussion Forum for Consumers With Health Insurance Questions
3. Primary Wave Media Launches 1-800-HOSPICE
4. Nanyang Technological University launches first-ever sports degree in Singapore
5. maxIT Healthcare Launches Healthcare Payer Professional Services Unit
6. PARI Respiratory Equipment Launches 2 New Continuing Ed Classes
7. Cambridge Healthtech Media Group Launches Clinical Trials Web Site
8. SilverCensus.com Launches National Website for Caregivers, Senior Citizens, Healthcare Professionals
9. Cleveland Clinic Launches Ground-Breaking Wellness Program To Reverse Effects of Common Chronic Diseases
10. Thomson Reuters Launches Liquent PublishPerfect(TM)
11. Tributes.com Launches Light a Candle Program In Support of the American Heart Association and Heart Health Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... 20, 2017 , ... ChenMed , a leading provider of value-based care ... Center as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of ... Officer of Ambulatory Services for the UVA Health System, brings 30 years of highly ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia ... that progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and ... and relapse. With such a challenging diagnosis that requires immediate action, patients ...
(Date:7/20/2017)... 20, 2017 (PRWEB) , ... ... ... a global provider of enterprise-grade IT operations analytics and application performance monitoring ... one of world’s largest healthcare services providers. , According to Peter Ohrenberger, ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... law firm headquartered in Houston, is pleased to announce their expansion to the ... affordable housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... For individuals ... utmost importance. The adjustable beds used in such facilities are specially designed to accommodate ... adequate arm support. , An inventor from Rochester, Ind., has invented the patent-pending ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... , July 11, 2017 Zymo Research Corp., also known ... that can quantify biological aging in a precise manner using the myDNAge ... Steve Horvath , a professor of human genetics and biostatistics at the ... School of Public Health , Zymo Research,s proprietary DNAge ™ technology ... ...
(Date:7/11/2017)... 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery ... Administration (FDA) has agreed to schedule an End-of-Phase II ... trial of its oral insulin capsule ORMD-0801 in the ... met primary and secondary endpoints by indicating a statistically ...
(Date:7/10/2017)... 2017 Locus Biosciences Inc. today announced the ... development of CRISPR-Cas3 antimicrobial therapeutics. Financing for the round ... Internet services provider, and joined by the North Carolina ... product programs targeting antibiotic resistant infections and other microbiome-related ... Dr. Rodolphe Barrangou and Dr. Charles ...
Breaking Medicine Technology: